Exploring type 2 inflammation and disease complexity: perspectives of a clinical immunologist
Type 2 inflammatory diseases are often grouped together as a single immunological entity, driven by shared cytokines and overlapping pathways. This framework has led to the development of biologic therapies targeting upstream epithelial-derived “alarmi…